Centro de Imagem Diagnósticos S.A (AALR3) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.071x

Based on the latest financial reports, Centro de Imagem Diagnósticos S.A (AALR3) has a cash flow conversion efficiency ratio of 0.071x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$78.10 Million ≈ $15.32 Million USD) by net assets (R$1.10 Billion ≈ $215.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Centro de Imagem Diagnósticos S.A (AALR3) net asset quality to measure how much of total assets are equity-financed.

Centro de Imagem Diagnósticos S.A - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Centro de Imagem Diagnósticos S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AALR3 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Centro de Imagem Diagnósticos S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Centro de Imagem Diagnósticos S.A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
IFB Agro Industries Limited
NSE:IFBAGRO
-0.018x
EA Technique M Bhd
KLSE:5259
0.067x
Lithium Ionic Corp
V:LTH
-0.113x
Swelect Energy Systems Limited
NSE:SWELECTES
0.069x
New Asia Construction & Development Corp
TW:2516
-0.226x
ATW Technology Inc
TWO:8097
-0.004x
Trinity Precision Technology Co Ltd
TWO:4534
0.024x
XL Holdings Bhd
KLSE:7121
-0.100x

Annual Cash Flow Conversion Efficiency for Centro de Imagem Diagnósticos S.A (2010–2024)

The table below shows the annual cash flow conversion efficiency of Centro de Imagem Diagnósticos S.A from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see Centro de Imagem Diagnósticos S.A market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 R$1.14 Billion
≈ $223.06 Million
R$-41.02 Million
≈ $-8.05 Million
-0.036x -133.30%
2023-12-31 R$943.99 Million
≈ $185.23 Million
R$102.30 Million
≈ $20.07 Million
0.108x -43.19%
2022-12-31 R$981.92 Million
≈ $192.67 Million
R$187.30 Million
≈ $36.75 Million
0.191x +54.70%
2021-12-31 R$1.21 Billion
≈ $237.31 Million
R$149.13 Million
≈ $29.26 Million
0.123x +28.02%
2020-12-31 R$1.22 Billion
≈ $240.11 Million
R$117.86 Million
≈ $23.13 Million
0.096x -40.42%
2019-12-31 R$1.32 Billion
≈ $259.01 Million
R$213.41 Million
≈ $41.87 Million
0.162x +30.36%
2018-12-31 R$1.30 Billion
≈ $255.03 Million
R$161.19 Million
≈ $31.63 Million
0.124x +17.39%
2017-12-31 R$1.27 Billion
≈ $249.25 Million
R$134.19 Million
≈ $26.33 Million
0.106x +62.12%
2016-12-31 R$1.21 Billion
≈ $237.80 Million
R$78.97 Million
≈ $15.50 Million
0.065x -51.54%
2015-12-31 R$733.00 Million
≈ $143.83 Million
R$98.56 Million
≈ $19.34 Million
0.134x +109.55%
2014-12-31 R$743.32 Million
≈ $145.85 Million
R$47.69 Million
≈ $9.36 Million
0.064x +4.79%
2013-12-31 R$279.49 Million
≈ $54.84 Million
R$17.11 Million
≈ $3.36 Million
0.061x -63.19%
2012-12-31 R$234.93 Million
≈ $46.10 Million
R$39.07 Million
≈ $7.67 Million
0.166x +29.64%
2011-12-31 R$257.14 Million
≈ $50.46 Million
R$32.99 Million
≈ $6.47 Million
0.128x -58.17%
2010-12-31 R$35.66 Million
≈ $7.00 Million
R$10.94 Million
≈ $2.15 Million
0.307x --

About Centro de Imagem Diagnósticos S.A

SA:AALR3 Brazil Diagnostics & Research
Market Cap
$99.83 Million
R$508.76 Million BRL
Market Cap Rank
#19172 Global
#181 in Brazil
Share Price
R$3.34
Change (1 day)
+0.60%
52-Week Range
R$2.56 - R$6.76
All Time High
R$24.30
About

Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more